Researchers developed a mouse model of multiple sclerosis that captures the features of progression independent of relapse ...

Generic comorbidity measures may not reflect the unique clinical profile of people with MS, hitting a predictive ceiling.

Emerging research has provided fresh evidence regarding the role of viral infection in the development of multiple sclerosis.

By Kamal Choudhury and Mariam Sunny Feb 6 (Reuters) - Biogen forecast annual profit above Wall Street estimates on Friday, banking on demand for newer medicines and strength of its promising ...

Appealing an insurance claim denial with multiple sclerosis often requires following the rules and being persistent.

With Biogen’s multiple sclerosis portfolio facing more generic pressure than ever, the company is eyeing a busy late-stage ...

Biogen swung to a loss as results were hurt by a double-digit decline in revenue from its core multiple sclerosis treatments.

TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the presentation of data highlighting BRIUMVI® (ublituximab-xiiy), to be presented at the Americas Committee for Treatment and Research in ...

Biogen forecast 2026 profit above Wall Street estimates on Friday, banking on demand for newer medicines and its Alzheimer's ...

Residents living with the condition will compete alongside international athletes across Abu Dhabi and Al Dhafra ...

Could plastic byproducts and forever chemicals found in drinking water cause your body to attack your own nervous system?

Researchers at UC San Francisco have uncovered a new clue to how Epstein-Barr virus (EBV) could contribute to multiple sclerosis (MS), a chronic autoimmune disease that affects nearly one million ...